Meta Health (SGX:5DX) addressed queries from the Singapore Exchange regarding its acquisition of a 55% stake in Jas Medical Screening Centre, according to a Thursday filing on the Singapore Exchange.
The company clarified that earn-out shares, valued at SG$77,770 per tranche, were calculated based on performance targets of SG$175,000 in annual net profit.
Adjustments to the earn-out shares will be independently reviewed, replacing the need for auditor opinions, Meta Health said.
Regarding its option agreement, the company said it allows flexibility for corporate transactions and divestments. The purchase price of option shares will be determined by mutual agreement or an expert valuer.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。